Venture-Backed Startups

Cellphire Therapeutics develops platelet-based and freeze-dried cellular therapeutics for transfusion medicine, focused on controlling hemorrhage. Through its veterinary subsidiary BodeVet, it also markets freeze-dried platelet products for companion and exotic animals.

2 investors

Cellply develops VivaCyte, an automated analytical platform for characterizing immune cells at single-cell resolution, used in the discovery and process development of cell therapies. The system handles sample preparation through image processing, analyzing over 100 samples per run and more than 1,000 single cells per sample.

3 investors

CellPoint Digital provides a payment optimisation and intelligence platform for travel businesses, connecting payment performance, routing, fraud management, FX optimisation, reporting and reconciliation into a single travel-focused layer. It also offers alternative payment methods, a hosted payment page and payment infrastructure aimed at improving approvals, lowering costs and reducing fraud for travel brands.

2 investors

Cellr provides a no-code platform that turns physical brand interactions and product touchpoints into measurable digital experiences, offering features such as competitions, loyalty, redemptions, brand protection, and real-time engagement analytics. It serves brands across multiple industries including beverage, FMCG, sports and entertainment, apparel, cosmetics, and pharmaceutical.

1 investor

CellRep uses AI to discover small molecules that rejuvenate immune cells without genetic modification, with a lead application enhancing CAR-T therapy against solid tumors. The compounds are applied ex vivo during manufacturing as reagents, building a platform for cellular rejuvenation spanning cancer immunotherapy and longevity.

2 investors

CellsBin develops an AI-driven photonic semiconductor platform for detecting, isolating, and characterizing rare cells in biological samples for therapeutic monitoring and precision medicine applications. The company serves researchers and clinicians in drug development, cell therapy monitoring, and clinical diagnostics.

1 investor

0 investors

CellSolutions develops products for cytopathology sample preparation, cellular preservation and presentation, and digital automated screening with diagnostic interpretation. It serves clinical diagnostic applications, drawing on expertise in diagnostic cytopathology, clinical biochemistry, image analysis, and software engineering.

0 investors

CellSonics develops SimpleFlow, an instrument that uses acoustic waves rather than enzymes to dissociate tissue into single cells, aiming to release more cells without bias. It is used in life sciences applications such as single-cell RNA sequencing, demonstrated on mouse brain tissue with higher preservation of astrocytes and neurons.

2 investors

CellTech Accelerator is a startup accelerator and fund focused on cell and gene therapy, supporting the commercialization of regenerative medicine technologies through preclinical consultation, clinical validation, leadership-building, and commercialization services. It positions itself as the first cell and gene therapy startup accelerator in Asia and operates a dedicated investment fund (CellTech Fund I).

1 investor

0 investors

0 investors

CellTivity Scientific develops the Van Gogh system, which uses Dynamic Cell Imaging to generate real-time metabolic "heat maps" of biopsy samples, helping proceduralists assess sample adequacy and identify cell types such as cancer and immune cells. The technology aims to improve diagnostic cancer sampling and maximize yield for next-generation sequencing in pathology.

1 investor

CellTrack develops a cell-labeling technology that attaches Zirconium-89 to therapeutic cells for non-invasive PET imaging, allowing tracking of cell biodistribution in vivo for over 7 days. The company targets pharma companies and CDMOs developing cell therapies, aiming to provide biodistribution data for clinical trials.

1 investor

CellTrak (HCHB) provides an electronic health record platform for home-based care agencies, integrating documentation, billing, and analytics into one system. It is designed to support care teams and manage patient visits for home care operations.

2 investors

Celltrio manufactures robotic automation systems for the life sciences industry, with patented technology for biobanking and cell culturing automation. The company licenses IP from a Korean robotics partner and develops products with a US-based engineering team.

1 investor

Celltrion is a biopharmaceutical company that researches, develops, manufactures, and markets biosimilars and novel biologic therapeutics across therapeutic areas including immunology, oncology, hematology, ophthalmology, and endocrinology. Its products include ZYMFENTRA (subcutaneous infliximab) for inflammatory bowel disease and a range of FDA-approved biosimilars.

3 investors

0 investors

CellType uses AI agents and biological models to automate drug discovery, having identified a novel cancer treatment signal and partnering with major pharmaceutical companies.

3 investors

CelluComp manufactures Curran, a patented bio-based platform derived from cellulose nanofibres extracted from vegetable waste, used to add strength and barrier properties to pulp and other materials as a replacement for plastics and PFAS. Its primary application is fibre-based barrier packaging for food, personal care, and home care products, with additional uses in industrial materials, paints and coatings.

1 investor

0 investors

0 investors

0 investors

Cellular Highways manufactures the Highway1 Cell Sorter, a benchtop instrument for high-throughput cell sorting applications in research. The company serves life science researchers requiring fast, gentle cell sorting with high cell viability.

1 investor